Menicon Undertakes With the Novovision Clinic a Paediatric Myopia Control Clinical Trial
"The MCOS study aims, using a rigorous study design and precise opticalmeasuring instruments, at elucidating whether orthokeratology lens wear slowsthe axial length growth of the eye in children with progressing myopia. Thisstudy is of special relevance taking into account that the prevalence ofmyopia has increased substantially over recent decades and now is approaching10-25% and 60-80% in industrialized societies of the West and East,respectively," commented Dr. Jacinto Santodomingo, Global ProfessionalRelations Manager for Menicon Co., Ltd.
"We have been fitting orthokeratology lenses in our clinic for severalyears, during which we observed that myopia tended to progress less inchildren wearing orthokeratology lenses compared to children wearing othermodalities of visual correction. We are delighted to participate in thisunique clinical trial, which should prove whether we are correct about ourpreliminary observations," added Mr. Cesar Villa, Director of Optometry atNovovision.
Menicon Co., Ltd. (www.menicon.com), founded by Mr. Kyoichi Tanaka in1951, is Japan's first and largest contact lens manufacturer, and now isrepresented in over 30 countries. Menicon is a manufacturer dedicated to allareas of soft and GP contact lens related businesses including materialdevelopment, lens designing, and manufacturing of contact lenses and caresolutions. Menicon is a world-leader in the development of hyper-Dk GP(Menicon Z) and soft contact lenses (Menicon PremiO).Contact: Toshio Matsushima Global Business Operations Menicon Co., Ltd. Phone: +81-52-937-5021 Fax: +81-52-935-1121 E-mail: email@example.com URL: http://www.menicon.com
SOURCE Menicon Co., Ltd.
You May Also Like